Provider
QP47-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy
Program effective Date: Jun 12, 2019
Search Results
Displaying 2711 - 2720 of 4139 results
Provider
QP57-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization Criteria: tafamidis
Program effective Date: Jun 12, 2019
Provider
QP49-19 Pharmacy Benefit Exclusion for Proventil (albuterol sulfate) HFA and Proventil (albuterol sulfate) HFA Authorized Generic (AG)
Program effective Date: Jun 12, 2019
Provider
QP54-19 Pharmacy Benefit Update – New Drug-Related Utilization Management Program: Opioid Immediate Release (IR) New to Therapy (NTT) Program
Program effective Date: Jun 12, 2019
Provider
QP52-19 Pharmacy Benefit Exclusion for Cimzia, Elzonris, Gamifant, Kalbitor, Khapzory, leucovorin calcium, Nuzyra and Panzyga
Program effective Date: Jun 12, 2019
Provider
QP53-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Neurotrophic Keratitis
Program effective Date: Jun 12, 2019
Provider
QP59-19 eviCore Group Number List to be Removed
Program effective Date: Jun 12, 2019
Provider
QP51-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Firdapse
Program effective Date: Jun 12, 2019
Provider
QP20R1-20 Update: Medical Drug Update for Teprotumumab (Tepezza)
Program effective Date: May 13, 2020
Provider
QP46-20 Validation of National Drug Codes Submitted with Medical Drug Claims
Program effective Date: May 13, 2020